Phenome-Wide Association Studies as a Tool to Advance Precision Medicine

Annual Review of Genomics and Human Genetics

Volumn 17, Issue , 2016, Pages 353-373

  Denny, Joshua C ^a   Bastarache, Lisa ^a   Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

electronic health record; genome wide association study; phenome wide association study; phenotyping

Indexed keywords

COMORBIDITY; ELECTRONIC HEALTH RECORD; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PERSONALIZED MEDICINE; PHENOMENOLOGY; REVERSE GENETICS; REVIEW; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TRENDS;

GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECISION MEDICINE;

EID: 84984922391     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090314-024956     Document Type: Review

References (85)

1. Boland MR, Hripcsak G, Albers DJ, Wei Y, Wilcox AB, et al. 2013. Discovering medical conditions associated with periodontitis using linked electronic health records. J. Clin. Periodontol. 40:474-82
2. Bowton E, Field JR, Wang S, Schildcrout JS, Van Driest SL, et al. 2014. Biobanks and electronic medical records: enabling cost-effective research. Sci. Transl. Med. 6:234cm3
3. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, et al. 2015. Ezetimibe added to statin therapy after acute coronary syndromes. N. Engl. J. Med. 372:2387-97
4. Carroll RJ, Bastarache L, Denny JC. 2014. R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment. Bioinformatics 30:2375-76
5. Chapman WW, Bridewell W, Hanbury P, Cooper GF, Buchanan BG. 2001. A simple algorithm for identifying negated findings and diseases in discharge summaries. J. Biomed. Inform. 34:301-10
6. Chen Z, Chen J, Collins R, Guo Y, Peto R, et al. 2011. China kadoorie biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int. J. Epidemiol. 40:1652-66
7. Claussnitzer M, Dankel SN, Kim K-H, Quon G, Meuleman W, et al. 2015. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373:895-907
8. Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. 2006. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354:1264-72
9. Cowen ME, Dusseau DJ, Toth BG, Guisinger C, Zodet MW, Shyr Y. 1998. Casemix adjustment of managed care claims data using the clinical classification for health policy research method. Med. Care 36:1108-13
10. Crawford DC, Crosslin DR, Tromp G, Kullo IJ, Kuivaniemi H, et al. 2014. Emerging progress in genomics - the first seven years. Front. Genet. 5:184
11. Cronin RM, Field JR, Bradford Y, Shaffer CM, Carroll RJ, et al. 2014. Phenome-wide association studies demonstrating pleiotropy of genetic variants within FTO with and without adjustment for body mass index. Appl. Genet. Epidemiol. 5:250
12. Crosslin DR, Carrell DS, Burt A, Kim DS, Underwood JG, et al. 2015. Genetic variation in the HLA region is associated with susceptibility to herpes zoster. Genes Immun. 16:1-7
13. Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, et al. 2012. Predicting clopidogrel response using DNA samples linked to an electronic health record. Clin. Pharmacol. Ther. 91:257-63
14. Denny JC. 2012. Chapter 13: Mining electronic health records in the genomics era. PLOS Comput. Biol. 8:e1002823
15. Denny JC, Arndt FV, Dupont WD, Neilson EG. 2008. Increased hospital mortality in patients with bedside hippus. Am. J. Med. 121:239-45
16. Denny JC, Bastarache L, Ritchie MD, Carroll RJ, Zink R, et al. 2013. Systematic comparison of phenomewide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31:1102-11
17. Denny JC, Crawford DC, Ritchie MD, Bielinski SJ, Basford MA, et al. 2011. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am. J. Hum. Genet. 89:529-42
18. Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, et al. 2010. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26:1205-10
19. Denny JC, Spickard A, Johnson KB, Peterson NB, Peterson JF, Miller RA. 2009. Evaluation of a method to identify and categorize section headers in clinical documents. J. Am. Med. Inform. Assoc. 16:806-15
20. Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, et al. 2015. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLOS ONE 10:e0122271
21. Doshi-Velez F, Ge Y, Kohane I. 2014. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics 133:e54-63
22. Ghebranious N, McCarty C, Wilke R. 2007. Clinical phenome scanning. Pers. Med. 4:175-82
23. Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, et al. 2013. The ElectronicMedical Records and Genomics (eMERGE) Network: past, present, and future. Genet. Med. 15:761-71
24. Grady BJ, Torstenson E, Dudek SM, Giles J, Sexton D, Ritchie MD. 2010. Finding unique filter sets in PLATO: a precursor to efficient interaction analysis in GWAS data. Pac. Symp. Biocomput. 2010:315-26
25. Hall MA, Verma A, Brown-Gentry KD, Goodloe R, Boston J, et al. 2014. Detection of pleiotropy through a phenome-wide association study (PheWAS) of epidemiologic data as part of the Environmental Architecture for Genes Linked to Environment (EAGLE) study. PLOS Genet. 10:e1004678
26. Harkema H, Dowling JN, Thornblade T, Chapman WW. 2009. ConText: an algorithm for determining negation, experiencer, and temporal status from clinical reports. J. Biomed. Inform. 42:839-51
27. Hebbring SJ, Rastegar-Mojarad M, Ye Z, Mayer J, Jacobson C, Lin S. 2015. Application of clinical text data for phenome-wide association studies (PheWASs). Bioinformatics 31:1981-87
28. Hebbring SJ, Schrodi SJ, Ye Z, Zhou Z, Page D, Brilliant MH. 2013. A PheWAS approach in studying HLA-DRB1∗1501. Genes Immun. 14:187-91
29. Humphreys BL, Lindberg DA, Schoolman HM, Barnett GO. 1998. The unifiedmedical language system: an informatics research collaboration. J. Am. Med. Inf. Assoc. 5:1-11
30. Jacobs LC, Liu F, Pardo LM, Hofman A, Uitterlinden AG, et al. 2015. IRF4, MC1R and TYR genes are risk factors for actinic keratosis independent of skin color. Hum. Mol. Genet. 24:3296-303
31. Jones R, Pembrey M, Golding J, Herrick D. 2005. The search for genenotype/phenotype associations and the phenome scan. Paediatr. Perinat. Epidemiol. 19:264-75
32. Karnes JH, Cronin RM, Rollin J, Teumer A, Pouplard C, et al. 2014. A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record. Thromb. Haemost. 113:772-81
33. Karol SE, Yang W, Van Driest SL, Chang TY, Kaste S, et al. 2015. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood 126:1770-76
34. Kawai VK, Cunningham A, Vear SI, Van Driest SL, Oginni A, et al. 2014. Genotype and risk of major bleeding during warfarin treatment. Pharmacogenomics 15:1973-83
35. Kho AN, Hayes MG, Rasmussen-Torvik L, Pacheco JA, Thompson WK, et al. 2012. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J. Am. Med. Inform. Assoc. 19:212-18
36. Kvale MN, Hesselson S, Hoffmann TJ, Cao Y, Chan D, et al. 2015. Genotyping informatics and quality control for 100, 000 subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort. Genetics 200:1051-60
37. Li L, Cheng W-Y, Glicksberg BS, Gottesman O, Tamler R, et al. 2015. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci. Transl. Med. 7:311ra174
38. Liao KP, Cai T, Gainer V, Goryachev S, Zeng-Treitler Q, et al. 2010. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res. 62:1120-27
39. Liao KP, Kurreeman F, Li G, Duclos G, Murphy S, et al. 2013. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis cases. Arthritis Rheum. 65:571-81
40. McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, et al. 2011. The eMERGE network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genom. 4:13
41. McDonald CJ. 1976. Protocol-based computer reminders, the quality of care and the non-perfectability of man. N. Engl. J. Med. 295:1351-55
42. McDonald CJ, Tierney WM. 1988. Computer-stored medical records: their future role in medical practice. JAMA 259:3433-40
43. McDonald CJ, Wilson GA, McCabe GP. 1980. Physician response to computer reminders. JAMA 244:1579-81
44. Melton GB, Hripcsak G. 2005. Automated detection of adverse events using natural language processing of discharge summaries. J. Am. Med. Inf. Assoc. 12:448-57
45. Millard LAC, Davies NM, Timpson NJ, Tilling K, Flach PA, Smith GD. 2015. MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization. Sci. Rep. 5:16645
46. Mitchell SL, Hall JB, Goodloe RJ, Boston J, Farber-Eger E, et al. 2014. Investigating the relationship between mitochondrial genetic variation and cardiovascular-related traits to develop a framework for mitochondrial phenome-wide association studies. BioData Min. 7:6
47. Moore CB, Verma A, Pendergrass S, Verma SS, Johnson DH, et al. 2015. Phenome-wide association study relating pretreatment laboratory parameters with human genetic variants in AIDS clinical trials group protocols. Open Forum Infect. Dis. 2:ofu113
48. Mosley JD, Brittain EL, Loyd JE, Denny JC, Austin ED, Larkin EK. 2015. Letter by Mosley regarding article, "Iron homeostasis and pulmonary hypertension: Iron deficiency leads to pulmonary vascular remodeling in the rat." Circ. Res. 117:e56-57
49. Mosley JD, Shaffer CM, Van Driest SL, Weeke PE, Wells QS, et al. 2016. A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough. Pharmacogenom. J. 16:231-37
50. Myocard. Infarct. Genet. Consort. Investig. 2014. Inactivatingmutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371:2072-82
51. Namjou B, Marsolo K, Caroll RJ, Denny JC, Ritchie MD, et al. 2014. Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to eosinophilic esophagitis. Front. Genet. 5:401
52. Namjou B, Marsolo K, Lingren T, Ritchie MD, Verma SS, et al. 2015. A GWAS study on liver function test using emerge network participants. PLOS ONE 10:e0138677
53. Neuraz A, Chouchana L, Malamut G, Le Beller C, Roche D, et al. 2013. Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLOS Comput. Biol. 9:e1003405
54. Newton KM, Peissig PL, Kho AN, Bielinski SJ, Berg RL, et al. 2013. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the emerge network. J. Am. Med. Inform. Assoc. 20:e147-54
55. Off. Natl. Coord. Health Inf. Technol. 2015. CMS Medicare and Medicaid EHR Incentive Program, electronic health record products used for attestation. Data Set, US Dep. Health Hum. Serv., Washington, DC. http://www.healthdata.gov/dataset/cms-medicare-and-medicaid-ehr-incentive-programelectronic- health-record-products-used
56. Okada Y, Wu D, Trynka G, Raj T, Terao C, et al. 2013. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:736-81
57. Pathak J, Kiefer RC, Bielinski SJ, Chute CG. 2012. Applying semantic web technologies for phenomewide scan using an electronic health record linked biobank. J. Biomed. Semant. 3:10
58. Pendergrass SA, Brown-Gentry K, Dudek S, Frase A, Torstenson ES, et al. 2013. Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture Using Genomics and Epidemiology (PAGE) Network. PLOS Genet. 9:e1003087
59. Pendergrass SA, Brown-Gentry K, Dudek SM, Torstenson ES, Ambite JL, et al. 2011. The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet. Epidemiol. 35:410-22
60. Pendergrass SA, Dudek SM, Crawford DC, Ritchie MD. 2012. Visually integrating and exploring high throughput phenome-wide association study (PheWAS) results using PheWAS-View. BioData Min. 5:5
61. Postmus I, Trompet S, Deshmukh HA, Barnes MR, Li X, et al. 2014. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat. Commun. 5:5068
62. Precis. Med. Initiat. Work. Group. 2015. The Precision Medicine Initiative Cohort Program - building a research foundation for 21st century medicine. Rep., Precis. Med. Initiat. Work. Group, Natl. Inst. Health, Bethesda, MD. http://acd.od.nih.gov/reports/DRAFT-PMI-WG-Report-9-11-2015-508.pdf
63. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. 2007. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559-75
64. Ramirez AH, Shi Y, Schildcrout JS, Delaney JT, Xu H, et al. 2012. Predictingwarfarin dosage inEuropean- Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics 13:407-18
65. Rastegar-Mojarad M, Ye Z, Kolesar JM, Hebbring SJ, Lin SM. 2015. Opportunities for drug repositioning from phenome-wide association studies. Nat. Biotechnol. 33:342-45
66. Ritchie MD, Denny JC, Crawford DC, Ramirez AH, Weiner JB, et al. 2010. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am. J. Hum. Genet. 86:560-72
67. Ritchie MD, Denny JC, Zuvich RL, Crawford DC, Schildcrout JS, et al. 2013. Genome- and phenomewide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation 127:1377-85
68. Sanseau P, Agarwal P, Barnes MR, Pastinen T, Richards JB, et al. 2012. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 30:317-20
69. Scannell JW, Blanckley A, Boldon H, Warrington B. 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11:191-200
70. Shameer K, Denny JC, Ding K, Jouni H, Crosslin DR, et al. 2014. A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Hum. Genet. 133:95-109
71. Simonti CN, Vernot B, Bastarache L, Bottinger E, Carrell DS, et al. 2016. The phenotypic legacy of admixture between modern humans and Neandertals. Science 351:737-41
72. Smemo S, Tena JJ, Kim K-H, Gamazon ER, Sakabe NJ, et al. 2014. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371-75
73. Sudlow C, Gallacher J, Allen N, Beral V, Burton P, et al. 2015. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLOS Med. 12:e1001779
74. Van Driest SL, McGregor TL, Velez Edwards DR, Saville BR, Kitchner TE, et al. 2015. Genome-wide association study of serum creatinine levels during vancomycin therapy. PLOS ONE 10:e0127791
75. Warner JL, Alterovitz G. 2012. Phenome based analysis as a means for discovering context dependent clinical reference ranges. AMIA Annu. Symp. Proc. 2012:1441-49
76. Warner JL, Alterovitz G, Bodio K, Joyce RM. 2013. External phenome analysis enables a rational federated query strategy to detect changing rates of treatment-related complications associated with multiple myeloma. J. Am. Med. Inform. Assoc. 20:696-99
77. Warner JL, Zollanvari A, Ding Q, Zhang P, Snyder GM, Alterovitz G. 2013. Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications. J. Am. Med. Inform. Assoc. 20:e281-87
78. Wei W-Q, Cronin RM, Xu H, Lasko TA, Bastarache L, Denny JC. 2013. Development and evaluation of an ensemble resource linking medications to their indications. J. Am. Med. Inform. Assoc. 20:954-61
79. Wei W-Q, Denny JC. 2015. Extracting research-quality phenotypes from electronic health records to support precision medicine. Genome Med. 7:1-14
80. Wei W-Q, Teixeira PL, Mo H, Cronin RM, Warner JL, Denny JC. 2016. Combining billing codes, clinical notes, andmedications from electronic health records provides superior phenotyping performance. J. Am. Med. Inform. Assoc. 23:e20-27
81. Wolfe D, Dudek S, Ritchie MD, Pendergrass SA. 2013. Visualizing genomic information across chromosomes with phenogram. BioData Min. 6:18
82. Wyatt J. 1994. Clinical data systems, part 1: data and medical records. Lancet 344:1543-47
83. Xu H, Stenner SP, Doan S, Johnson KB, Waitman LR, Denny JC. 2010. MedEx: amedication information extraction system for clinical narratives. J. Am. Med. Inform. Assoc. 17:19-24
84. Yao L, Li Y, Ghosh S, Evans JA, Rzhetsky A. 2015. HealthROI as ameasure of misalignment of biomedical needs and resources. Nat. Biotechnol. 33:807-11
85. Ye Z, Mayer J, Ivacic L, Zhou Z, He M, et al. 2014. Phenome-wide association studies (PheWASs) for functional variants. Eur. J. Hum. Genet. 23:523-29